These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 17588391

  • 1. Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
    Colli A, Campodonico R, Gherli T.
    Ann Thorac Surg; 2007 Jul; 84(1):87-91. PubMed ID: 17588391
    [Abstract] [Full Text] [Related]

  • 2. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A.
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
    Jasovich A, Ganaha MC, Ebi C, García RD, Blanco MA, Lopardo H.
    Rev Argent Microbiol; 2008 Oct; 40(4):204-7. PubMed ID: 19213241
    [Abstract] [Full Text] [Related]

  • 5. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS, Sorensen SV, Liu LZ, Itani KM.
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S.
    Clin Infect Dis; 2001 May 01; 32(9):1373-5. PubMed ID: 11303275
    [Abstract] [Full Text] [Related]

  • 8. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W.
    Int J Antimicrob Agents; 2008 Sep 01; 32(3):241-9. PubMed ID: 18635341
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K.
    J Antimicrob Chemother; 2008 Aug 01; 62(2):381-3. PubMed ID: 18445576
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ.
    Clin Infect Dis; 2006 Mar 01; 42(5):597-607. PubMed ID: 16447103
    [Abstract] [Full Text] [Related]

  • 16. Early experience with linezolid for infections in orthopaedics.
    Harwood PJ, Talbot C, Dimoutsos M, Sunderland G, Shaw D, Wilcox MH, Giannoudis PV.
    Injury; 2006 Sep 01; 37(9):818-26. PubMed ID: 16620816
    [Abstract] [Full Text] [Related]

  • 17. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
    Menzin J, Marton JP, Meyers JL, Carson RT, Rothermel CD, Friedman M.
    Am J Infect Control; 2010 Feb 01; 38(1):44-9. PubMed ID: 19762120
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM, Weigelt J, Li JZ, Duttagupta S.
    Int J Antimicrob Agents; 2005 Dec 01; 26(6):442-8. PubMed ID: 16289514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.